HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience.

AuthorsP Gaviani, G Simonetti, A Salmaggi, E Lamperti, A Silvani
JournalJournal of neuro-oncology (J Neurooncol) Vol. 113 Issue 3 Pg. 527-9 (Jul 2013) ISSN: 1573-7373 [Electronic] United States
PMID23703296 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Brain Neoplasms (drug therapy, mortality, pathology)
  • Female
  • Follow-Up Studies
  • Glioma (drug therapy, mortality, pathology)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Recurrence, Local (drug therapy, mortality, pathology)
  • Nitrosourea Compounds (therapeutic use)
  • Organophosphorus Compounds (therapeutic use)
  • Prognosis
  • Prospective Studies
  • Salvage Therapy
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: